1 6 membrane traffic, rather than a generalized function recruiting OCRL. The F&H motif containing 1 OCRL/INPP5B interactors APPL1 and Ses1/2 (IPIP27A/B), were thought to appear later in evolution 2 than OCRL, as searches of databases had detected APPL1 only in vertebrates 3 and Ses/CG12393 in 3 Drosophila and other insects, but not in unicellular organisms 10 . In contrast, OCRL/INPP5B-like 4 proteins are widely present in unicellular organisms. Amino acids critically required for the F&H 5 interacting surface of OCRL 4 were highly conserved even in these ancestral OCRL species, 6 suggestive of the presence of yet-to-be-identified F&H interactors in these evolutionary older 7 organisms. 8
We tested this possibility in the social amoeba D. discoideum, which expresses a single OCRL 9 orthologue, Dd5P4, displaying an F&H interacting surface. Loss of Dd5P4 is not lethal 30 , but leads 1 0 to quantifiable defects in macropinocytosis and growth 29 , which can be rescued by expression of 1 1 GFP-fusions of Dd5P4 and of human OCRL, suggesting closely conserved function and subcellular 1 2 targeting 29 . 1 3
To our surprise, we found that the identity of the F&H proteins that interact with OCRL is as well-1 4 conserved as the F&H surface itself: in both humans and amoeba, OCRL uses the F&H interface to 1 5 couple to three proteins, a BAR-domain protein present at the earliest stages of endocytosis (APPL1 1 6 in humans and OIBP in D. discoideum), a PH-domain containing protein on late 1 7 lysosomes/postlysosomes (Ses1/2 in humans and PIO in D. discoideum), and a novel interactor GxcU/ 1 8 Frabin, a Rho family GEF, which in humans is associated with the disorder Charcot Marie Tooth 1 9
Type 4. Live imaging of GxcU and Frabin showed that both proteins appear at multiple early and later 2 0 stages of endocytosis. Our data suggests that there is a specific requirement of OCRL phosphatase 2 1 activity coordinated by different F&H proteins at well-delineated endocytic stations. 2 2
We also established a novel function for OCRL-like phosphatases in membrane trafficking: in 2 3 addition to known phenotypes of Dd5P4 loss in D. discoideum 29, 30, 49, 53 , (reduced growth and a defect 2 4
in both micropinocytosis and phagocytosis), we identified a novel phenotype in axenic cells: Dd5P4 2 5 controls the rate of fusion and endocytic tubulation/recapture of an osmoregulatory organelle, the 2 6 1 7
contractile vacuole (CV). CV exocytosis is thought to be a "kiss-and-run" process, involving minimal 1 mixing of the CV membrane with the plasma membrane 54 . 2
Notably, we found that Dd5P4 has two separable functions in the CV discharge process: CV fusion, 3 which did not depend on F&H peptide interactions but was blocked by overexpression of a 4 catalytically inactive Dd5P4 fusion protein, and tubulation/reformation (which we indicate as 5 'collapse phase'), whose kinetic was influenced by F&H-mediated interactions. We measured 6 extended kinetics of the CV 'collapse phase' in GFP-Dd5P4 W602A expressing mutants (where the CV 7 fusion rate defects in Dd5P4 knockouts is restored), and the extended kinetics of the OIBP-GFP 8 fusion protein in this same stage in Dd5P4 -. 9
How Dd5P4 interferes with CV fusion is yet unclear, although several functions of OCRL/Dd5P4 1 0 might be implicated. Disturbances of the actin cytoskeleton cause inappropriate mixing of CV and 1 1 plasma membranes 45 , leading to CV-resident proton pumps being found at the plasma membrane. 1 2
Similarly, 'spillover' of the transmembrane protein Dajumin, responsible for the biogenesis of CVs, is 1 3 retrieved from the plasma membrane via clathrin/AP2 55 , where mammalian OCRL is also known to 1 4 act. Thus it is possible that Dd5P4 could have several functions on this organelle, for example 1 5 regulating underlying actin and/or PI(4,5)P 2 at the CV fusion site, or in trafficking of receptors which 1 6 are necessary for the CV fusion/reformation cycle.Our images of GFP-Dd5P4 D419G show that this 1 7 mutant protein remains clustered in punctae upon arriving to docked CVs, whereas GFP-Dd5P4 WT 1 8 and GFP-Dd5P4 W620A arrive at CVs prior to fusion and then spread over the CV membrane, 1 9 coincident with the CV starting to fuse and decrease in size. Previous work 54,56 suggests that during 2 0 this phase of the CV cycle (docking and fusion-ready) CVs are labelled by Drainin and Rab8 and 2 1 undergo 'ring to patch' transition to allow full fusion. In the absence of the 'ring to patch' transition 2 2 (f.e. in P2XA mutant CVs 56 ) CV fusion becomes inefficient, as we have seen in Dd5P4mutants. In 2 3 contrast, the more severe phenotype of GFP-Dd5P4 D419G suggests that this mutant may sequester 2 4 factors such as Rab8 GTP . Indeed the swollen CV phenotype found in GFP-Dd5P4 D419G is reminiscent 2 5 of the Rab8 DN and draininphenotypes previously published 54 . 2 6 1 8
While there is no direct analogue of this organelle in mammals, the CV is decorated by the small 1 GTPase Rab8 prior to its exocyst-directed fusion with the plasma membrane 54 . Rab8 is a strong 2 interactor of OCRL in mammals 57,58 , where the interaction is responsible for membrane traffic to the 3 primary cilium 21 . Interestingly, both CV fusion in D. discoideum 54 and growth of cilia involve fusion 4 via the exocyst complex 59 , suggesting OCRL may serve an analogous function in both contexts. 5
The PH domain protein PIO, like its higher-organism counterpart Ses1/2, is a late endocytic protein, 6 only being present on endocytic organelles that are reached by fluid-phase endocytic tracer 30 7 minutes or more after ingestion (Figure 3) , consistent with a late-endosomal or lysosomal function. 8
The localization of the newly identified OCRL/Dd5P4 interactor, GxcU/Frabin, was particularly 9
intriguing. In human cells, Frabin-GFP has a similar multi-stage recruitment pattern to both early and 1 0 late endosomal and macropinocytic membranes 60, 61, 62 (Figure 2, Supplementary Movie 1) . In D. 1 1 discoideum, GxcU-GFP was recruited to several distinct stages of the endocytic pathway ( Figures 4E  1  2 and F), both at what would be considered very early (at the base of the macropinocytic crown) and at 1 3 the site of reforming CVs, several seconds after the timepoint when the other F&H interactor, OIBP-1 4 GFP appears (e.g. Figure 5A ). While the target of the GxcU GEF activity is not known, the 1 5 localization of GxcU to macropinosomes is highly reminiscent of the localization of active Rac1 63,64 . 1 6
Interestingly, overexpression of GxcU-GFP phenocopied Dd5P4 loss in terms of fluid-phase dye 1 7 uptake and processing and enhanced the Dd5P4mutant phenotype (Figure 7 ), suggesting that Dd5P4 1 8 may be a repressor of GxcU function. 1 9
In summary, our findings reveal that the network of F&H peptide interactors of OCRL is more 2 0 evolutionary conserved than expected based on previous studies. Furthermore, in all cases that we 2 1 examined, selective disruption of the F&H interface of OCRL/Dd5P4 does not significantly impair its 2 2 localization, but impacts downstream reactions. In D. discoideum, F&H mutant Dd5P4 localizes to 2 3 the same subcompartments as wildtype Dd5P4, but where we made kinetic measurements, we found 2 4 that lack of F&H interactions affected the kinetics of the trafficking step under study. Likewise F&H-2 5 containing interactors of Dd5P4 were recruited to membranes for longer periods in Dd5P4mutants 2 6 1 9 than in wild type, suggesting that co-ordinated activity of OCRL and F&H adaptors is necessary for 1 efficient membrane progression. 2
Our study gives weight to the possibility of functionally relevant amounts of PI(4,5)P 2 being present 3 in the endocytic system under normal conditions. Recent research suggests that PI(4,5)P 2 and/or 4 OCRL catalytic activity has a critical role in membrane traffic separate from its role in at the plasma 5 membrane, including transition from early to late endosomes 65-68 and the transition from endosome to 6 trans-Golgi 8, 22 . The presence of conserved, endomembrane-specific interactors for OCRL argues 7 against a function of OCRL solely as a cellular 'housekeeper', and suggests instead that OCRL-8 directed PI(4,5)P 2 on endosomes is assisted and directed by interaction with F&H proteins. 9
Fibroblasts from OCRL-mutated Lowe Syndrome or Dent2 patients are equally deficient in PI(4,5)P 2 1 0 phosphatase activity 69 , however Dent2 disease fibroblasts manifest milder phenotypes (e.g. the 1 1 degree of defective actin stress fibre formation, abnormal alpha-actinin staining and shortened 1 2 primary cilia 69 ) than their Lowe syndrome counterparts, suggesting the presence of a modifier gene on 1 3 an autosome. The OCRL paralog INPP5B has been excluded as a phenotype modifier in Lowe/Dent2 1 4 patients 69 . Given that the F&H interaction is so well conserved and appears to change the kinetics of 1 5
OCRL-dependant membrane trafficking steps, F&H proteins should be considered as highly likely 1 6 candidates for modifiers of the Lowe syndrome phenotype. 
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